Kimberly Robell

Kimberly Robell is a seasoned professional in the field of oncology, currently serving as Director of Translational Sciences at HotSpot Therapeutics, Inc. since April 2023, having previously held the position of Associate Director in the same department. Prior experience includes roles at PMV Pharmaceuticals, Inc. from January 2018 to April 2023, where Kimberly advanced from Clinical Biomarker Manager to Senior Clinical Biomarker Manager. Other notable positions include Senior Research Scientist at Bristol-Myers Squibb and Senior Associate Scientist at Janssen. Kimberly's career began as a Research Associate at Onconova Therapeutics and includes significant tenure at GSK and Merck. Kimberly holds a B.S. in Small Animal Science from Delaware Valley University, earned from 1997 to 2001.